Dr. Howard Steven Mitz, D.O. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 220 Cottage St, Littleton, NH 03561 Phone: 603-444-0272 Fax: 603-444-0274 |
News Archive
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.
Researchers at the University of North Carolina School of Medicine announced the publication of results from a multi-site phase 2 clinical trial with brexanolone, an investigational medication, in the treatment of severe postpartum depression.
A new study shows that a kind of E. coli most associated with "travelers' diarrhea" and children in underdeveloped areas of the world causes more severe disease in people with blood type A.
According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren't receiving potentially lifesaving treatment.
SXC Health Solutions Corp., a leading provider of technology and pharmacy benefit management services, announces its financial results for the three-month and six-month periods ended June 30, 2011.
› Verified 6 days ago